At a glance
ClinicalIndex Comparison RecordN/ACompleted· 92 enrolled
Drug / intervention
Serafilcon A toric contact lenses +2 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Performance Evaluation of Two Frequent Replacement Silicone Hydrogel Toric Contact Lenses
In Brief
A clinical study evaluating Serafilcon A toric contact lenses, Senofilcon A toric contact lenses, and 1 other intervention for Ametropia and 3 related conditions. Completed, enrolled 92 participants across 7 sites.
Detailed Summary
The primary objective of this study is to evaluate the axis orientation of LID226397 toric contact lenses.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAmetropia, Myopia, Hyperopia, Astigmatism
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
202420252026
First PostedJul 2023
Enrollment StartAug 2023
Primary CompletionOct 2023
TodayJul 2026
First PostedJul 25, 2023
Enrollment StartAug 14, 2023
Primary CompletionOct 23, 2023
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 2.9 years ago
Interventions
Serafilcon A toric contact lensesdevice
Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)
Senofilcon A toric contact lensesdevice
Silicone hydrogel contact lenses for the optical correction of refractive ametropia (myopia or hyperopia with astigmatism)
CLEAR CAREdevice
Hydrogen peroxide-based contact lens cleaning and disinfecting solution